Detected ·
Alethio Therapeutics
£67MSeries A
Alethio Therapeutics secures a £67m Series A round led by Sofinnova Partners and RA Capital Management to develop targeted blood cancer therapies.
- Website
- —
- linkedin.com/company/76644628
- Amount
- £67 000 000 GBP
- Stage
- Series A
- Event
- Funding round
- Detected
- 2026-11-06 08:06:23 UTC
- Signal ID
- 0589273b-4a5f-4aef-ab39-b0c1e9710282
As the API returns it
{
"id": "0589273b-4a5f-4aef-ab39-b0c1e9710282",
"created_at": "2026-11-06T08:06:23.022154Z",
"company_name": "Alethio Therapeutics",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/76644628",
"event_type": "funding",
"funding_amount": 67000000,
"funding_currency": "GBP",
"funding_stage": "series_a",
"message": "*Alethio Therapeutics secures a £67m Series A round led by Sofinnova Partners and RA Capital Management to develop targeted blood cancer therapies.*"
}